デフォルト表紙
市場調査レポート
商品コード
1428334

がん診断向けAIの世界市場レポート 2024

Artificial Intelligence In Cancer Diagnostics Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 175 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.31円
がん診断向けAIの世界市場レポート 2024
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 175 Pages
納期: 2~10営業日
  • 全表示
  • 概要
  • 目次
概要

がん診断向けAIの市場規模は、今後数年間で急激に成長すると予想されています。 2028年には30.8%の年間複合成長率(CAGR)で11億8,000万米ドルに成長すると予想されます。予測期間の成長は、臨床医不足、高齢化、遠隔医療の世界の導入、AIと電子医療記録の統合、がん検診プログラムの拡大に起因すると考えられます。予測期間の主な動向には、AIアルゴリズムの急速な進歩、イメージング技術の進歩、病理学の技術革新、ラジオミクスとラジオゲノミクスの発展、創薬、ディープラーニング、予測バイオマーカー発見のためのAIが含まれます。

予想されるがん症例の急増により、がん診断向けAI市場の拡大が促進されることになります。さまざまな臓器に影響を与える制御されていない細胞増殖を特徴とするがんは、依然として世界の健康上の重大な課題となっています。人工知能は、医療画像データの正確かつ効率的な分析を容易にすることで、がん診断において極めて重要な役割を果たします。これにより、がん性病変の早期発見と正確な分類が可能になります。たとえば、2023年 10月、欧州連合サイエンスハブは、2022年の新規がん症例数は過去2年間と比較して2.3%増加して274万人になると報告しました。これに対応して、がん関連死亡率は同期間中に2.4%増加しました。したがって、がんの有病率がエスカレートすることで、がん診断向けAI市場の成長が促進されると予想されます。

医療インフラの継続的な強化により、予見可能な将来にがん診断向けAI市場が促進される見込みです。医療サービスをサポートする基本的なフレームワーク、施設、リソース、プロセスを含む医療インフラは、AIテクノロジーのシームレスな統合にとって重要です。堅牢な医療インフラにより、臨床ワークフローへのAIの組み込みが可能になり、データのセキュリティとプライバシーが確保され、医療機関全体での共同作業が促進されます。特に、2022年3月、オーストラリアの保健・高齢者ケア省は、2022~23年に医療インフラに1,320億米ドルの大幅な配分を発表し、2025~26年には1,400億米ドルに増加しました。今後4年間で5,370億米ドルというこのコミットメントは、がん診断向けAI市場を推進する上で医療インフラの改善が極めて重要な役割を果たしていることを強調しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018~2023年
  • 市場規模と成長予測、2023~2028年、2033年

第6章 市場セグメンテーション

  • がん診断向けAIの世界市場、コンポーネント別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • ソフトウェアソリューション
  • ハードウェア
  • サービス
  • がん診断向けAIの世界市場、がんの種類別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 乳がん
  • 肺がん
  • 前立腺がん
  • 結腸直腸がん
  • 脳腫瘍
  • その他
  • がん診断向けAIの世界市場、アプリケーション別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • スクリーニング・診断
  • 腫瘍の特定
  • 監視
  • 治療
  • がん診断向けAIの世界市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • 医学研究機関
  • 診断センター
  • 受託研究組織

第7章 地域および国の分析

  • がん診断向けAIの世界市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • がん診断向けAIの世界市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • がん診断向けAI市場の競合情勢
  • がん診断向けAI市場の企業プロファイル
    • Microsoft Corporation
    • Pfizer Inc.
    • Johnson &Johnson's
    • Siemens
    • Roche Holding AG

第31章 その他の大手および革新的な企業

  • Google LCC
  • International Business Machines Corporation
  • Thermo Fisher Scientific Inc.
  • Oracle Corporation
  • GE Healthcare
  • Illumina Inc.
  • Bio Rad Laboratories Inc.
  • Flatiron Health
  • Tempus Labs Inc.
  • Paige AI Inc.
  • OncoHealth Corporation
  • Path AI Inc.
  • Aidoc
  • AliveCor Inc.
  • Sophia Genetics SA

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

目次
Product Code: r14179

Artificial intelligence (AI) in cancer diagnostics involves the application of advanced computational techniques and algorithms to aid in the detection, diagnosis, and characterization of cancer. This technology is employed to enhance the speed, accuracy, and efficiency of cancer imaging tests, achieving comparable accuracy to radiologists in detecting mammographic abnormalities.

The main components of artificial intelligence in cancer diagnostics include software solutions, hardware, and services. Software solutions are customized applications or systems designed to address specific business needs, and AI-powered software in cancer diagnostics utilizes machine learning algorithms and computer vision techniques to analyze medical images, genetic data, and clinical records. This enables accurate cancer detection, classification, and treatment prediction. These AI applications are utilized in various types of cancer such as breast cancer, lung cancer, prostate cancer, colorectal cancer, and brain tumors. They are applied in screening and diagnosis, tumor identification, surveillance, and treatment planning and are used by hospitals, medical research institutes, diagnostic centers, and contract research organizations.

The artificial intelligence in cancer diagnostics research report is one of a series of new reports from The Business Research Company that provides artificial intelligence in cancer diagnostics market statistics, including the artificial intelligence in cancer diagnostics industry's global market size, regional shares, competitors with an artificial intelligence in cancer diagnostics market share, detailed artificial intelligence in cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence in cancer diagnostics industry. This artificial intelligence in cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence in cancer diagnostics market size has grown exponentially in recent years. It will grow from $0.3 billion in 2023 to $0.4 billion in 2024 at a compound annual growth rate (CAGR) of 34.0%. The growth in the historic period can be attributed to the increased incidence of cancer, the availability of big data, the rise of personalized oncology, initiatives in precision medicine, and the integration of genomic data.

The artificial intelligence in cancer diagnostics market size is expected to see exponential growth in the next few years. It will grow to $1.18 billion in 2028 at a compound annual growth rate (CAGR) of 30.8%. The growth in the forecast period can be attributed to clinician shortages, population aging, the global adoption of telemedicine, the integration of AI with electronic health records, and the expansion of cancer screening programs. Major trends in the forecast period include rapid advances in AI algorithms, advancements in imaging technology, technological innovations in pathology, developments in radiomics and radiogenomics, drug development, deep learning, and AI for predictive biomarker discovery.

The anticipated surge in cancer cases is set to drive the expansion of the artificial intelligence in the cancer diagnostics market. Cancer, characterized by uncontrolled cell growth impacting various organs, remains a significant global health challenge. Artificial intelligence plays a pivotal role in cancer diagnostics by facilitating accurate and efficient analysis of medical imaging data. This enables early detection and precise classification of cancerous lesions. For example, in October 2023, the European Union Science Hub reported a 2.3% increase in new cancer cases to 2.74 million in 2022 compared to the previous two years. Correspondingly, cancer-related mortality rose by 2.4% during the same period. Hence, the escalating prevalence of cancer is expected to fuel the growth of the artificial intelligence in the cancer diagnostics market.

The ongoing enhancement of healthcare infrastructure is poised to drive the artificial intelligence in cancer diagnostics market in the foreseeable future. Healthcare infrastructure, encompassing the fundamental framework, facilities, resources, and processes supporting healthcare services, is crucial for the seamless integration of AI technologies. A robust healthcare infrastructure enables the incorporation of AI into clinical workflows, ensures data security and privacy, and facilitates collaborative efforts across healthcare institutions. Notably, in March 2022, the Department of Health and Aged Care in Australia announced a substantial allocation of $132 billion to healthcare infrastructure in 2022-23, rising to $140 billion in 2025-26. This commitment of $537 billion over the next four years underscores the pivotal role of improving healthcare infrastructure in propelling the artificial intelligence in cancer diagnostics market.

Technological advancement emerges as a prominent trend gaining momentum in the artificial intelligence in the cancer diagnostics market. Key market players are focused on developing innovative tools catering to various cancer conditions, thereby fortifying their market positions. For instance, in March 2023, Qritive, a Singapore-based company specializing in AI-powered solutions for pathologists, introduced QAi Prostate-an advanced AI-powered tool for prostate cancer diagnosis. QAi Prostate accurately identifies prostatic adenocarcinoma regions and classifies malignant and benign tumor areas in biopsy tissue samples. This tool provides detailed summaries of tumor size and percentage for each slide or region of interest, empowering pathologists to make informed decisions rapidly.

Strategic collaborations are a significant approach adopted by major companies operating in the artificial intelligence in cancer diagnostics market to expedite the deployment of AI-powered technologies. Such partnerships leverage the strengths and resources of collaborating entities for mutual benefits. For instance, in October 2023, F. Hoffmann-La Roche AG collaborated with Ibex Medical Analytics and Amazon Web Services. This collaboration allows pathology labs to utilize the navify Digital Pathology software platform to access Ibex's AI-powered decision support capabilities, aiding physicians in diagnosing breast and prostate cancer. The partnership between Ibex Medical Analytics, Roche, and Amazon Web Services generates innovative AI-powered processes, fostering advancements in digital pathology and offering scalable solutions for pathology laboratories.

In January 2022, RadNet, a US-based radiology information technology solutions company, acquired Aidence Holding B.V. and Quantib B.V. This strategic acquisition addresses opportunities in lung and prostate cancer diagnosis and screening through artificial intelligence. Aidence Holding B.V., based in the Netherlands, focuses on AI-powered clinical applications for the lung cancer pathway, while Quantib B.V. specializes in AI and machine learning solutions for prostate cancer.

Major companies operating in the artificial intelligence in cancer diagnostics market report are Microsoft Corporation, Pfizer Inc., Johnson & Johnson's, Siemens, Roche Holding AG, Google LCC, International Business Machines Corporation, Thermo Fisher Scientific Inc., Oracle Corporation, GE Healthcare, Illumina Inc., Bio Rad Laboratories Inc., Flatiron Health, Tempus Labs Inc., Paige AI Inc., OncoHealth Corporation, Path AI Inc., Aidoc, AliveCor Inc., Sophia Genetics SA, Digital Diagnostics Inc., Prognos Health, Aidence, Kheiron Medical Technologies Limited, Zebra Medical Vision, Niramai, Enlitic Inc., Therapixel, Medial EarlySign Ltd., Freenome, SkinVision B.V.

North America was the largest region in the artificial intelligence in cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence in cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in the cancer diagnostics market consists of revenues earned by entities by providing services such as data analysis, image recognition, personalized medicine, and decision support. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the cancer diagnostics market also includes sales of AI-based diagnostic tools, predictive analytics tools, and a virtual tumor board. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence In Cancer Diagnostics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence in cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence in cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence in cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Component: Software Solutions; Hardware; Services
  • 2) By Cancer Type: Breast Cancer; Lung Cancer; Prostate Cancer; Colorectal Cancer; Brain Tumor; Other Types
  • 3) By Application: Screening And Diagnosis; Tumor Identification; Surveillance; Treatment
  • 4) By End-User: Hospitals; Medical Research Institute; Diagnostic Centers; Contract Research Organization
  • Companies Mentioned: Microsoft Corporation; Pfizer Inc.; Johnson & Johnson's; Siemens; Roche Holding AG
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence In Cancer Diagnostics Market Characteristics

3. Artificial Intelligence In Cancer Diagnostics Market Trends And Strategies

4. Artificial Intelligence In Cancer Diagnostics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Artificial Intelligence In Cancer Diagnostics Market Size and Growth

  • 5.1. Global Artificial Intelligence In Cancer Diagnostics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Artificial Intelligence In Cancer Diagnostics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Artificial Intelligence In Cancer Diagnostics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Artificial Intelligence In Cancer Diagnostics Market Segmentation

  • 6.1. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Software Solutions
  • Hardware
  • Services
  • 6.2. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Cancer Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Breast Cancer
  • Lung Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Brain Tumor
  • Other Types
  • 6.3. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Screening And Diagnosis
  • Tumor Identification
  • Surveillance
  • Treatment
  • 6.4. Global Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Medical Research Institute
  • Diagnostic Centers
  • Contract Research Organization

7. Artificial Intelligence In Cancer Diagnostics Market Regional And Country Analysis

  • 7.1. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Artificial Intelligence In Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market

  • 8.1. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Artificial Intelligence In Cancer Diagnostics Market

  • 9.1. China Artificial Intelligence In Cancer Diagnostics Market Overview
  • 9.2. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Artificial Intelligence In Cancer Diagnostics Market

  • 10.1. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Artificial Intelligence In Cancer Diagnostics Market

  • 11.1. Japan Artificial Intelligence In Cancer Diagnostics Market Overview
  • 11.2. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Artificial Intelligence In Cancer Diagnostics Market

  • 12.1. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Artificial Intelligence In Cancer Diagnostics Market

  • 13.1. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Artificial Intelligence In Cancer Diagnostics Market

  • 14.1. South Korea Artificial Intelligence In Cancer Diagnostics Market Overview
  • 14.2. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Artificial Intelligence In Cancer Diagnostics Market

  • 15.1. Western Europe Artificial Intelligence In Cancer Diagnostics Market Overview
  • 15.2. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Artificial Intelligence In Cancer Diagnostics Market

  • 16.1. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Artificial Intelligence In Cancer Diagnostics Market

  • 17.1. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Artificial Intelligence In Cancer Diagnostics Market

  • 18.1. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Artificial Intelligence In Cancer Diagnostics Market

  • 19.1. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Artificial Intelligence In Cancer Diagnostics Market

  • 20.1. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market

  • 21.1. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market Overview
  • 21.2. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Artificial Intelligence In Cancer Diagnostics Market

  • 22.1. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Artificial Intelligence In Cancer Diagnostics Market

  • 23.1. North America Artificial Intelligence In Cancer Diagnostics Market Overview
  • 23.2. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Artificial Intelligence In Cancer Diagnostics Market

  • 24.1. USA Artificial Intelligence In Cancer Diagnostics Market Overview
  • 24.2. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Artificial Intelligence In Cancer Diagnostics Market

  • 25.1. Canada Artificial Intelligence In Cancer Diagnostics Market Overview
  • 25.2. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Artificial Intelligence In Cancer Diagnostics Market

  • 26.1. South America Artificial Intelligence In Cancer Diagnostics Market Overview
  • 26.2. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Artificial Intelligence In Cancer Diagnostics Market

  • 27.1. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Artificial Intelligence In Cancer Diagnostics Market

  • 28.1. Middle East Artificial Intelligence In Cancer Diagnostics Market Overview
  • 28.2. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Artificial Intelligence In Cancer Diagnostics Market

  • 29.1. Africa Artificial Intelligence In Cancer Diagnostics Market Overview
  • 29.2. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Component, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Artificial Intelligence In Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape And Company Profiles

  • 30.1. Artificial Intelligence In Cancer Diagnostics Market Competitive Landscape
  • 30.2. Artificial Intelligence In Cancer Diagnostics Market Company Profiles
    • 30.2.1. Microsoft Corporation
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Pfizer Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Johnson & Johnson's
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Siemens
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Roche Holding AG
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Artificial Intelligence In Cancer Diagnostics Market Other Major And Innovative Companies

  • 31.1. Google LCC
  • 31.2. International Business Machines Corporation
  • 31.3. Thermo Fisher Scientific Inc.
  • 31.4. Oracle Corporation
  • 31.5. GE Healthcare
  • 31.6. Illumina Inc.
  • 31.7. Bio Rad Laboratories Inc.
  • 31.8. Flatiron Health
  • 31.9. Tempus Labs Inc.
  • 31.10. Paige AI Inc.
  • 31.11. OncoHealth Corporation
  • 31.12. Path AI Inc.
  • 31.13. Aidoc
  • 31.14. AliveCor Inc.
  • 31.15. Sophia Genetics SA

32. Global Artificial Intelligence In Cancer Diagnostics Market Competitive Benchmarking

33. Global Artificial Intelligence In Cancer Diagnostics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Artificial Intelligence In Cancer Diagnostics Market

35. Artificial Intelligence In Cancer Diagnostics Market Future Outlook and Potential Analysis

  • 35.1 Artificial Intelligence In Cancer Diagnostics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Artificial Intelligence In Cancer Diagnostics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Artificial Intelligence In Cancer Diagnostics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer